Back to top

Analyst Blog

On Jun 17, 2013, shares of UnitedHealth Group Inc. (UNH - Analyst Report) hit a 52-week high of $65.24. The momentum was driven by recent hike in dividend as well as new share repurchase announcement. 
 
Shares of the company gained 20.6% year to date as of the close of trading on Monday.
 
UnitedHealth recently announced that its Board of Directors has authorized a substantial hike of 32% in its quarterly dividend to 28 cents per share. The company’s board also approved the repurchase of 110 million shares, which is about 10% of UnitedHealth’s outstanding shares. These actions reflect the company’s strong balance sheet position with a moderate leverage and ability to generate significant cash flow.
 
We are also optimistic regarding the company’s long-term growth prospects. It has strengthened its key capabilities to respond to the emerging growth opportunities. These initiatives have been taken to expand its Medicaid and Medicare business, grow the health service business and expand the international operations.
 
UnitedHealth has also been aggressively expanding its overseas business, which will provide the company geographical diversification benefits. With increased regulations from the Health Care Law at home the company is looking for business from international venues. 
 
UnitedHealth has been successfully growing its membership. With the implementation of TRICARE Contract, it added 2.9 million military market beneficiaries.
 
Valuation for UnitedHealth looks reasonable. The shares are trading at a discount to the peer group average both on a forward price-to-earnings basis and on a price-to-book basis with return on equity lower than the peer group average. The year-to-date return from the stock came in at 18.7%, above the S&P’s return of 14.9%.
 
Other Stocks to Consider
 
Apart from UnitedHealth, other stocks in the industry that are currently performing well include Aetna Inc. (AET - Analyst Report) with Zacks Rank #1 (Strong Buy), Health Net Inc. (HNT - Analyst Report) and WellPoint Inc. (WLP - Analyst Report) both with Zacks Rank  #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
RPC INC RES 24.91 +8.35%
LITHIA MOTO… LAD 94.59 +4.60%
DELTA AIR L… DAL 39.15 +3.90%
FLAMEL TECH… FLML 14.51 +3.50%
SOUTHWEST A… LUV 28.87 +2.92%